What is OrthoPediatrics's R&D?

OrthoPediatrics (KIDS) reported R&D of $2.23M in Q1 2026.

How has OrthoPediatrics's R&D changed year-over-year?

OrthoPediatrics's R&D decreased by 5.1% year-over-year, from $2.35M to $2.23M.

What is the long-term trend for OrthoPediatrics's R&D?

Over 4 years (2021 to 2025), OrthoPediatrics's R&D has grown at a 13.2% compound annual growth rate (CAGR), from $5.54M to $9.1M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

OrthoPediatrics KIDS R&D

R&D at other companies

StrykerSYK

$413M+2.0%

Orthofix Medical Inc.OFIX

$15.32M-22.5%

Zimmer Biomet HoldingsZBH

$103.4M-6.5%

MedtronicMDT

$671M-1.9%

Alphatec HoldingsATEC

$17.56M+5.9%

SI-BONE, Inc.SIBN

$4.19M-7.5%

Other financials

Income statement

See full

Revenue$59.4M+13.3%

Gross profit$43.4M+13.4%

Operating income-$8.3M+24.1%

Net income-$10.7M-0.3%

EPS (diluted)-$0.45+2.2%

Balance sheet

See full

Cash & equivalents$14.2M-59.8%

Total debt$5.4M+271%

Total equity$338.7M-2.4%

Total assets$502.2M+6.8%

Cash flow

See full

Operating cash flow-$3.3M+20.9%

CapEx$1.8M-58.4%

Free cash flow-$5.0M+39.8%

Valuation

See full

Market cap$503.94M+0.3%

Enterprise value$495.11M+5.7%

P/S2.1×-0.3×

Profitability

See full

Gross margin73.1%+0.3pp

Operating margin-15%-1.6pp

Net margin-16.3%-2.1pp

FCF margin-12.9%-4.3pp

Returns & leverage

See full

Return on equity-11.6%+0.2pp

Debt / equity0×0.0×

Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OrthoPediatrics's R&D?: OrthoPediatrics (KIDS) reported R&D of $2.23M in Q1 2026.
How has OrthoPediatrics's R&D changed year-over-year?: OrthoPediatrics's R&D decreased by 5.1% year-over-year, from $2.35M to $2.23M.
What is the long-term trend for OrthoPediatrics's R&D?: Over 4 years (2021 to 2025), OrthoPediatrics's R&D has grown at a 13.2% compound annual growth rate (CAGR), from $5.54M to $9.1M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.